Somerset Theraps Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOMERSET THERAPS LLC
SOMERSET THERAPS LLC has seventy-nine approved drugs.
Summary for Somerset Theraps Llc
| US Patents: | 0 |
| Tradenames: | 69 |
| Ingredients: | 68 |
| NDAs: | 79 |
Drugs and US Patents for Somerset Theraps Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Somerset Theraps Llc | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 207636-004 | Jun 15, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | DROXIDOPA | droxidopa | CAPSULE;ORAL | 214543-002 | May 5, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | CLONIDINE HYDROCHLORIDE | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211433-001 | Oct 12, 2018 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 209013-002 | Apr 17, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Somerset Theraps Llc | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 213590-003 | Aug 31, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
